-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Arrowhead Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q2 2024.
- Arrowhead Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000, a 100% decline year-over-year.
- Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2024 was -$2.77M.
- Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $2.78M.
- Arrowhead Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $3.79M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)